Do you work with non-human biological material or genetic digital data? If so, you need to understand the basics of the Nagoya Protocol and your obligations as a researcher in the European Union.
Benefits arising use of genetic resources – whether for commercial or non-commercial purposes - must be shared with the countries where these materials come from. This is the principle of Access and Benefit-Sharing (ABS), governed by the Nagoya Protocol. But there is more, ongoing international negotiations on Digital Sequence Information (DSI), which broadly refers to genetic sequence data and other related digital data (RNA, proteins), are shaping new rules for benefit-sharing. Users of this kind of digital data must be aware.
But what exactly does this mean for you in practice?
In this workshop, we will break down the key legal aspects and practicalities of the Nagoya Protocol and the EU ABS Regulation. We will clarify which regulations apply, what are your legal obligation in the EU, and the consequences of non-compliance. We will also explore practical case studies, and look at current global policy developments on benefit-sharing from DSI. Plus, you’ll have the opportunity to get your specific legal questions answered by experienced experts.
This session is designed to provide hands-on experience and tailored guidance for your research projects. We look forward to your participation!
Please complete the survey available at the following link: Survey Link. This will help us get an overview of your research projects and needs in preparation for the event.
The data will be processed in accordance to the Privacy Policy of the German Federation for Biological Data (GFBio). The detailed version can be found here: https://www.gfbio.org/privacy-policy.
Please feel free to contact us (training@gfbio.org) if you have specific inquiries.
German Collection of Microorganisms and Cell Cultures GmbH I DSMZ; German Federation for Biological Data I GFBio e.V.